Brazil said last Monday (June 8, 2026) that it was temporarily suspending use of the world’s first single-dose dengue vaccine following two suspicious deaths.
More than half a million people have received doses of the vaccine this year (2026), which was developed publicly in Brazil and approved by health authorities in November (2025).
